CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to RHHBY

Englumafusp alfa

Phase 2
Roche Holding AG (RHHBY)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Q1 '27
RHHBYPhase 2

Englumafusp alfa Phase 2 Est. Readout

Englumafusp alfa
Q1 2027~Q
CT.gov
00%
Competitive Landscape

0 competitors in Lymphoma, Non-Hodgkin

View Full Landscape
Drug Information

Target Indication

Lymphoma, Non-Hodgkin

Clinical Trial

NCT04077723

Last updated: 1/7/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.